Calgary, Alberta
Canada
30
2015-08-13
29
2017-04-04
These are the the leading inventors for applications assigned to Oncolytics Biotech Inc.:
Oncolytics Biotech Inc. based in Calgary, Alberta, CA has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Lyophilized viral formulations
#2 | 2015-08-13 ✅ Patent 9,610,309 granted on 2017-04-04Liquid viral formulations
#3 | 2014-07-03 ✅ Patent 10,039,827 granted on 2018-08-07Reoviruses having modified sequences
#4 | 2014-06-26 ✅ Patent 10,167,452 granted on 2019-01-01Viral purification methods
#5 | 2013-10-17 ✅ Patent 9,365,823 granted on 2016-06-14Virus clearance of neoplastic cells from mixed cellular compositions
#6 | 2013-01-17 ✅ Patent 8,658,158 granted on 2014-02-25Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus
#7 | 2012-06-21 ✅ Patent 8,491,886 granted on 2013-07-23Viruses for the treatment of cellular proliferative disorders
#8 | 2012-06-07 ✅ Patent 9,044,498 granted on 2015-06-02Lyophilized viral formulations
#9 | 2012-06-07 ✅ Patent 8,709,443 granted on 2014-04-29Reovirus for the treatment of cellular proliferative disorders
#10 | 2012-06-07 ✅ Patent 9,045,728 granted on 2015-06-02Liquid viral formulations
#11 | 2011-08-18 ✅ Patent 8,491,884 granted on 2013-07-23Virus clearance of neoplastic cells from mixed cellular compositions
#12 | 2011-01-27 ✅ Patent 8,691,241 granted on 2014-04-08Reoviruses having modified sequences
#13 | 2011-01-20 ✅ Patent 8,071,087 granted on 2011-12-06Reovirus for the treatment of cellular proliferative disorders
#14 | 2010-08-12 ✅ Patent 8,080,241 granted on 2011-12-20Viruses for the treatment of cellular proliferative disorders
#15 | 2010-06-10 ✅ Patent 8,298,785 granted on 2012-10-30Use of ribozymes in the detection of adventitious agents
#16 | 2010-01-28 ✅ Patent 7,964,187 granted on 2011-06-21Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus
#17 | 2009-08-13ADENOVIRUSES MUTATED IN THE VA GENES FOR CANCER TREATMENT
#18 | 2009-05-07 ✅ Patent 8,066,985 granted on 2011-11-29Reovirus for the treatment of cellular proliferative disorders
#19 | 2009-02-05 ✅ Patent 7,803,385 granted on 2010-09-28REOVIRUSES HAVING MODIFIED SEQUENCES
#20 | 2008-09-18 ✅ Patent 7,803,385 granted on 2010-09-28Reoviruses having modified sequences
#21 | 2008-03-27 ✅ Patent 7,708,987 granted on 2010-05-04Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
#22 | 2008-02-07 ✅ Patent 7,964,186 granted on 2011-06-21Viruses for the treatment of cellular proliferative disorders
#23 | 2008-01-24 ✅ Patent 7,582,289 granted on 2009-09-01Viruses for the treatment of cellular proliferative disorders
#24 | 2008-01-24 ✅ Patent 7,799,329 granted on 2010-09-21Viruses for the treatment of cellular proliferative disorders
#25 | 2007-08-07 ✅ Patent 7,252,817 granted on 2007-08-07Viruses for the treatment of cellular proliferative disorders
#26 | 2007-04-03 ✅ Patent 7,198,783 granted on 2007-04-03Sensitization of neoplastic cells to radiation therapy with reovirus
#27 | 2006-10-19 ✅ Patent 7,344,711 granted on 2008-03-18Use of adenoviruses mutated in the VA genes for cancer treatment
#28 | 2006-08-03 ✅ Patent 7,815,914 granted on 2010-10-19Methods for the treatment of cellular proliferative disorders
#29 | 2006-04-06 ✅ Patent 7,452,723 granted on 2008-11-18Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
#30 | 2005-03-24 ✅ Patent 7,374,752 granted on 2008-05-20Reovirus for the treatment of cellular proliferative disorders
251877 ⎘